Nomination and validation of the long noncoding RNA SChLAP1 as a risk factor for metastatic prostate cancer progression: a multi-institutional high-throughput analysis

BACKGROUND: Improved clinical predictors for disease progression are needed for localized prostate cancer, where only a minority of patients experience poor outcomes. We undertake an unbiased large-scale analysis of genes associated with aggressive clinical course. METHODS: Prostate cancer samples,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lancet Oncol
Auteurs principaux: Prensner, John R., Zhao, Shuang, Erho, Nicholas, Schipper, Matthew, Iyer, Matthew K., Dhanasekaran, Saravana M., Magi-Galluzzi, Cristina, Mehra, Rohit, Sahu, Anirban, Siddiqui, Javed, Davicioni, Elai, Den, Robert B., Dicker, Adam P., Karnes, R. Jeffrey, Wei, John T., Klein, Eric A., Jenkins, Robert B., Chinnaiyan, Arul M., Feng, Felix Y.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559342/
https://ncbi.nlm.nih.gov/pubmed/25456366
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(14)71113-1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires